Bcal Diagnostics Ltd Cash Flow Reinvestment Rate
Latest as of December 2020:
0.00x
Bcal Diagnostics Ltd cash flow reinvestment rate. Bcal Diagnostics Ltd (BDX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting AU$5.00 (capex AU$5.00 ) from operating cash flow of AU$118.98K. Explore Bcal Diagnostics Ltd (BDX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
AU$5.00
Capex + Investments
Operating Cash Flow
AU$118.98K
AUD
Capital Expenditures
AU$5.00
AUD
Bcal Diagnostics Ltd Cash Flow Reinvestment Rate by Year (None–None)
Bcal Diagnostics Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Bcal Diagnostics Ltd. For the full cash flow conversion analysis, see BDX cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow